两种新辅助化疗方案对乳腺癌患者近期疗效及生存率的影响(3)
[2] Patel T，Gupta A，Shah M. Pathological predictive factorsfor tumor response in locally advanced breast carcinomastreated with anthracyclin-based neoadjuvant chemotherapy[J]. J Cancer Res Ther，2013，9(2)：245-249.[3] 韩芸蔚，温绍艳，刘伟，等. 乳腺癌新辅助化疗的临床评价方法解析[J]. 中国肿瘤临床，2011，38(7)：415-418.
[4] Yao X，Hosenpud J，Chitambar CR，et al. A phase Ⅱstudy of concurrent docetaxel，epirubicin and cyclophosphamide as a neoadjuvant chemotherapy regimen in patientswith locally advanced breast cancer[J]. J Cancer ......
您现在查看是摘要页，全文长 3769 字符。